Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Debt to Equity (2023 - 2025)

Historic Debt to Equity for Utah Medical Products (UTMD) over the last 8 years, with Q3 2025 value amounting to $0.0.

  • Utah Medical Products' Debt to Equity changed N/A to $0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.0, marking a year-over-year change of. This contributed to the annual value of $0.0 for FY2024, which is 445.51% up from last year.
  • According to the latest figures from Q3 2025, Utah Medical Products' Debt to Equity is $0.0.
  • Utah Medical Products' Debt to Equity's 5-year high stood at $0.0 during Q4 2024, with a 5-year trough of $0.0 in Q3 2025.
  • Over the past 3 years, Utah Medical Products' median Debt to Equity value was $0.0 (recorded in 2023), while the average stood at $0.0.
  • Data for Utah Medical Products' Debt to Equity shows a peak YoY increase of 445.51% (in 2024) and a maximum YoY decrease of 445.51% (in 2024) over the last 5 years.
  • Over the past 3 years, Utah Medical Products' Debt to Equity (Quarter) stood at $0.0 in 2023, then increased by 4.46% to $0.0 in 2024, then fell by 15.14% to $0.0 in 2025.
  • Its last three reported values are $0.0 in Q3 2025, $0.0 for Q1 2025, and $0.0 during Q4 2024.